英文名称 |
中文名称 |
CAS |
Dutasteride Impurity 3
|
非那雄胺EP杂质B |
103335-41-7 |
Azelastine Impurity 2
|
氮卓斯汀杂质2 |
153408-27-6 |
Ambroxol Impurity 4(Ambroxol EP Impurity A)
|
氨溴索杂质4(氨溴索EP杂质A) |
50739-76-9 |
Dutasteride Impurity 5
|
度他雄胺杂质5 |
164656-22-8 |
Dutasteride Impurity 2
|
度他雄胺杂质2 |
957229-52-6 |
Cinacalcet Impurity 1 ((S)-Isomer)(Cinacalcet USP Related Compound D HCl)
|
西那卡塞杂质1(S异构体)(西那卡塞USP杂质D盐酸盐) |
1217809-88-5 |
Dabigatran Impurity 8
|
达比加群杂质F |
1642853-67-5 |
Sorafenib Impurity 16
|
索拉非尼杂质16 |
1431697-81-2 |
Sorafenib Impurity 31
|
索拉非尼杂质31 |
1012058-78-4 |
Celecoxib Impurity 2
|
塞来昔布杂质2 |
170571-01-4 |
Irbesartan Impurity 1(Irbesartan EP Impurity A)
|
厄贝沙坦杂质1(厄贝沙坦EP杂质A) |
748812-53-5 |
Enzalutamide Impurity 11
|
恩杂鲁胺杂质11 |
2030242-21-6 |
Allisartan Isoproxil Impurity 15
|
西那卡塞杂质7 |
2200269-28-7 |
Sunitinib Impurity 10
|
舒尼替尼杂质10 |
2411816-47-0 |
Azelastine Impurity 6(Azelastine EP Impurity D)
|
氮卓斯汀杂质6(氮卓斯汀EP杂质D) |
53242-88-9 |
Cinacalcet Impurity 4
|
西那卡塞杂质4 |
1813-96-3 |
Celecoxib Impurity 4(Celecoxib EP Impurity B)
|
塞来昔布杂质4(塞来昔布EP杂质B) |
331943-04-5 |
Salmeterol Impurity 7(Salmeterol EP Impurity F )
|
沙美特罗杂质7(沙美特罗EP杂质F) |
1391054-40-2 |
Cinacalcet Impurity 10
|
西那卡塞杂质10 |
802918-47-4 |
Sorafenib Impurity 12
|
索拉非尼杂质12 |
2206827-14-5 |
Sorafenib Impurity 20
|
索拉非尼杂质20 |
6144-78-1 |
Celecoxib Impurity 9
|
塞来昔布杂质9 |
53764-99-1 |
Azelastine Impurity 4(Azelastine EP Impurity B)
|
氮卓斯汀杂质4(氮卓斯汀EP杂质B) |
117078-69-0 |
Celecoxib Impurity 3(Celecoxib EP Impurity A)
|
塞来昔布杂质3(塞来昔布EP杂质A) |
170570-01-1 |
Celecoxib Impurity 1
|
塞来昔布杂质1 |
170569-99-0 |
Vinpocetine Impurity 7
|
长春西汀杂质7 |
77549-94-1 |
Bromhexine Impurity 3(Bromhexine EP Impurity C)
|
溴己新杂质3(溴己新EP杂质C) |
57365-08-9 |
Sorafenib Impurity 24
|
索拉非尼杂质24 |
39974-35-1 |
Sorafenib Impurity 9
|
索拉非尼杂质9 |
284462-37-9 |
Cinacalcet Impurity 8
|
西那卡塞杂质8 |
3886-70-2 |
Dutasteride
|
度他雄胺 |
164656-23-9 |
Cinacalcet Impurity 3
|
西那卡塞杂质3 |
955373-56-5 |
Sorafenib Impurity 14
|
索拉非尼杂质14 |
1285533-84-7 |
Sorafenib Impurity 8
|
索拉非尼杂质8 |
320-51-4 |
Hydrochlorothiazide Impurity 2
|
氢氯噻嗪杂质2 |
5784-45-2 |
Celecoxib Impurity 7
|
塞来昔布杂质7 |
2629980-83-0 |
Regorafenib Impurity 25
|
瑞格非尼杂质25 |
18585-06-3 |
Sorafenib Impurity 15
|
索拉非尼杂质15 |
343247-69-8 |
Celecoxib Impurity 11
|
塞来昔布杂质11 |
1061214-06-9 |
Salmeterol Impurity 5(Salmeterol EP Impurity D )
|
沙美特罗杂质5(沙美特罗EP杂质D) |
1391052-04-2 |
Darifenacin Impurity 2
|
达非那新杂质2 |
943034-52-4 |
Darifenacin Impurity 1
|
达非那新杂质1 |
1092800-15-1 |
Cinacalcet Impurity 6
|
西那卡塞杂质6 |
253337-60-9 |
Enzalutamide Impurity 2
|
恩杂鲁胺杂质2 |
1242137-16-1 |
Dabigatran Impurity 6
|
达比加群酯杂质6 |
1610758-22-9 |
Dabigatran Impurity 9
|
达比加群酯杂质9 |
1408238-36-7 |
Enzalutamide Impurity 1
|
恩杂鲁胺杂质1 |
1242137-15-0 |
Cinacalcet Impurity 2(Cinacalcet USP RC C)
|
西那卡塞杂质2(西那卡塞USP杂质C) |
1428118-39-1 |
Sorafenib Impurity 11
|
索拉非尼杂质11 |
2004659-85-0 |
Irbesartan
|
厄贝沙坦 |
138402-11-6 |
Sorafenib Impurity 1
|
索拉非尼杂质1 |
2206827-12-3 |
Bromhexine Impurity 5(Bromhexine EP Impurity E)
|
溴己新杂质5(溴己新EP杂质E) |
1661064-00-1 |
Hydrochlorothiazide Impurity 1
|
氢氯噻嗪杂质1 |
5233-42-1 |
Dabigatran Impurity 2
|
达比加群酯杂质2 |
212321-78-3 |
Salmeterol Impurity 8(Salmeterol EP Impurity G )
|
沙美特罗杂质8(沙美特罗EP杂质G) |
1391051-88-9 |
Emtricitabine
|
恩曲他滨 |
143491-57-0 |
Dutasteride Impurity 6(Dutasteride EP Impurity C)
|
度他雄胺杂质6(度他雄胺EP杂质C) |
157307-36-3 |
Dabigatran Impurity 14
|
达比加群酯杂质14 |
1422435-41-3 |
Dabigatran Impurity 4
|
达比加群酯杂质4 |
1408238-40-3 |
Vinpocetine Impurity 5
|
长春西汀杂质5 |
85647-43-4 |
Sorafenib Impurity 34
|
索拉非尼杂质34 |
114780-06-2 |
Hydrochlorothiazide
|
氢氯噻嗪 |
58-93-5 |
Penehyclidine
|
戊乙奎醚 |
87827-02-9 |
Dabigatran
|
达比加群标准品 |
211914-51-1 |
Celecoxib Impurity 8
|
塞来昔布杂质8 |
26974-15-2 |
Dabigatran Etexilate
|
达比加群酯 |
211915-06-9 |
Enzalutamide
|
恩杂鲁胺 |
915087-33-1 |
Cinacalcet Impurity 5(Cinacalcet USP RC B)
|
西那卡塞杂质5(西那卡塞USP杂质B) |
1271930-15-4 |
Sorafenib Impurity 30
|
索拉非尼杂质30 |
845306-04-9 |
Salmeterol Impurity 3(Salmeterol EP Impurity B )
|
沙美特罗杂质3(沙美特罗EP杂质B) |
94749-02-7 |
Enzalutamide Impurity 5
|
恩杂鲁胺杂质5 |
915087-16-0 |
Celecoxib Impurity 13
|
塞来昔布杂质13 |
170570-09-9 |
Sorafenib Impurity 26
|
索拉非尼杂质26 |
288-32-4 |
Cinacalcet Impurity 13
|
西那卡塞杂质13 |
1622173-72-1 |
Cinacalcet
|
西那卡塞 |
364782-34-3 |
Celecoxib Impurity 5
|
塞来昔布杂质5 |
170571-00-3 |
Emtricitabine Impurity 1
|
恩曲他滨杂质1 |
145986-11-4 |
Dabigatran Impurity 10
|
达比加群酯杂质10 |
211915-84-3 |
Dabigatran Impurity 16
|
达比加群酯杂质16 |
429658-95-7 |
Celecoxib Impurity 18
|
塞来昔布杂质18 |
1061214-09-2 |
Sorafenib Impurity 13
|
索拉非尼杂质13 |
1129683-88-0 |
Dutasteride Impurity 1(Dutasteride EP Impurity E)
|
度他雄胺杂质1(度他雄胺EP杂质E) |
2102935-76-0 |
Vinpocetine Impurity 6
|
长春西汀杂质6 |
42971-12-0 |
Dabigatran Impurity 15
|
达比加群酯杂质15 |
1381757-44-3 |
Sorafenib Impurity 32
|
索拉非尼杂质32 |
88330-63-6 |
Salmeterol Impurity 2(Salmeterol EP Impurity A )
|
沙美特罗杂质2(沙美特罗EP杂质A) |
1798014-51-3 |
Diclofenac Impurity 1(Diclofenac EP Impurity D)
|
双氯芬酸杂质1(双氯芬酸EP杂质D) |
127792-23-8 |
Dutasteride Impurity 10
|
度他雄胺杂质10 |
103335-55-3 |
Amylmetacresol
|
氢氯噻嗪杂质B |
121-30-2 |
Sorafenib
|
索拉非尼 |
475207-59-1 |
Salmeterol Impurity 6(Salmeterol EP Impurity E )
|
沙美特罗杂质6(沙美特罗EP杂质E) |
108928-81-0 |
Bromhexine Impurity 4(Bromhexine EP Impurity D)
|
溴己新杂质4(溴己新EP杂质D) |
132004-28-5 |
Dutasteride Impurity 7(Dutasteride EP Impurity F)
|
度他雄胺杂质7(度他雄胺EP杂质F) |
1365545-42-1 |
Salmeterol Impurity 4(Salmeterol EP Impurity C )
|
沙美特罗杂质4(沙美特罗EP杂质C) |
94749-11-8 |
Dabigatran Impurity 12
|
达比加群酯杂质12 |
211915-00-3 |
Celecoxib Impurity 16
|
塞来昔布杂质16 |
915280-81-8 |
Enzalutamide Impurity 3
|
恩杂鲁胺杂质3 |
1242137-18-3 |
Dabigatran Impurity 5
|
达比加群酯杂质5 |
2225986-95-6 |
Sorafenib Impurity 27(Sorafenib N-Oxide)
|
索拉非尼杂质27(索拉非尼氮氧化物) |
583840-03-3 |
Darifenacin
|
达非那新 |
133099-07-7 |